Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 46Recruiting 28Unknown 23Terminated 23Not yet recruiting 14Active not recruiting 14Withdrawn 6Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 2Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Mesothelioma 1Lymphoma, T-Cell 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1HTLV-I Infections 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Etoposide 2Cisplatin 2Carboplatin 2durvalumab 1Radiosurgery 1Platinum 1Paclitaxel 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × Etoposide × Clear all
NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡